Nursing & Health

Permanent URI for this collectionhttps://research.avondale.edu.au/handle/123456789/457

Browse

Search Results

  • Item
    Which Trial do we Need? Gown and Glove use Versus Standard Precautions for Patients Colonized or Infected with methicillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococcus
    (Elsevier, 2024-08) Browning, Sarah; White, Nicole M.; Raby, Edward; Davis, Joshua S.; Mitchell, Brett G.
    Background Gown and glove use as a component of ‘contact precautions’ was first recommended by the United States Healthcare Infection Control Practices Advisory Committee in 1996 and remains widely adhered to today. Despite a lack of randomized trial evidence in support of this practice, donning of gowns and gloves upon entry to the patient area (room or cubicle) continues to be ‘strongly recommended’ when the patient is infected or colonized with pathogens of epidemiological importance
  • Item
    A Point Prevalence Study of Healthcare Associated Urinary Tract Infections in Australian Acute and Aged Care Faciltiies
    (2016-11-01) Gardner, Anne; Bennett, Noleen; Beckingham, Wendy; Fasugba, Oyebola; Mitchell, Brett G.

    Most healthcare-associated urinary tract infections (HAUTIs) including catheter associated urinary tract infections (CAUTIs) are potentially preventable through implementation of effective strategies. To provide the foundation for a national point prevalence study of HAUTIs including CAUTIs, a three phase project was developed. This study reports the findings of Phase II which aimed to (1) pilot an online process including online database for conducting point prevalence survey of HAUTIs and CAUTIs and (2) determine the point prevalence of HAUTIs and CAUTIs in acute and aged care facilities

  • Item
    Tasmanian Acute Public Hospitals Healthcare Associated Infection Surveillance Report 24 - Quarter 4 2014
    (2015-11-01) McGregor, Alistair; Wilson, Fiona; Wells, Anne; Mitchell, Brett G.

    This quarterly surveillance report provides an overview of the Tasmanian acute public hospitals healthcare associated infection surveillance. The TIPCU website (www.dhhs.tas.gov.au/tipcu) contains details of the surveillance program and the methodologies used in data collection, validation and analysis. These details are not contained in this report but are freely available online should further information be required.

  • Item
    Evaluating Environmental Cleanliness in Hospitals and Other Healthcare Settings
    (2012-03-01) Dancer, Stephanie; McGregor, Alistair; Brown, Saffron; Ware, Chris; Wilson, Fiona; Mitchell, Brett G.

    The purpose of this review is to describe some of the main methodologies currently used in assessing environmental cleanliness as well as document current local, national and international practices.

  • Item
    Preventing Healthcare Associated Infections: The Role of Surveillance
    (2015-02-04) Russo, Philip; Mitchell, Brett G.

    Surveillance of healthcare-associated infections is central to healthcare epidemiology and infection control programmes and a critical factor in the prevention of these infections. By definition, the term ‘infection prevention’ implies that healthcare-associated infections may be preventable. The purpose of surveillance is to provide quality data that can be used in an effective monitoring and alert system and to reduce the incidence of preventable healthcare-associated infections. This article examines the purpose of surveillance, explains key epidemiological terms, provides an overview of approaches to surveillance and discusses the importance of validation.

  • Item
    Moving Forward With Healthcare Infection
    (2012-09-01) Mitchell, Brett G.
  • Item
    NCFE Understanding and Prevention of MRSA: Level 2
    (2007-05-23) Mitchell, Brett G.

    This study directed study guide provides you with an overview of methicillin resistant Staphylococcus aureus (MRSA). Reservoirs, transmission and infection control prevention strategies are provided.

  • Item
    NCFE Understanding MRSA (Inc Numeracy) L2
    (2009-10-12) Rew, Ray; Mitchell, Brett G.

    This study directed study guide provides you with an overview of methicillin resistant Staphylococcus aureus (MRSA). Reservoirs, transmission and infection control prevention strategies are provided.

  • Item
    A Literature Review Supporting the Proposed National Australian Definition for Staphylococcus Aureus Bacteraemia
    (2010-12-01) Cruickshank, Marilyn; Stewart, Lee; Collignon, Peter; Gardner, Anne; Mitchell, Brett G.

    Staphylococcus aureus bacteraemia (SAB) is a major cause of morbidity and mortality. During 2009, a national surveillance definition for SAB was developed through the Australian Commission on Safety and Quality in Healthcare (ACSQHC). The aim of this paper is to review the literature surrounding SAB surveillance and in doing so, evaluate the recently developed Australian national definition for SAB. The issues examined in this paper that relate to SAB surveillance include detection, the management of duplicates, classification and acquisition of SAB. Upon reviewing the literature, it was clear that the national Australian SAB surveillance definitions developed by the ACSQHC Healthcare Associated Infection Surveillance Committee are consistent with the majority of literature. Where inconsistencies exist, for example the lack of acquisition information in SAB surveillance programs in the United Kingdom, it is clear that the Australian surveillance definitions are more robust and provide more useful information. The national surveillance definitions for SAB developed by the ACSQHC surveillance committee sets an improved standard for other countries.

  • Item
    Clostridium Difficile Infection in Tasmanian Public Hospitals 2006-2010
    (2011-09-01) Wells, Anne; Brown, Saffron; McGregor, Alistair; Ware, Chris; Mitchell, Brett G.

    Objective To describe the current epidemiology of Clostridium difficile infection (CDI) in Tasmania Design, setting and participants Tasmania undertakes continuous surveillance for CDI at all public hospitals. Data on cases of CDI between 2006 and 2010 were examined. All positive tests occurring within 8 weeks of a previous case, and cases occurring in children less than 2 years old were excluded, consistent with national definitions. Only cases identified at public hospitals were included in the analysis Main outcome measures The rate of CDI in Tasmanian hospitals over the study period and the ability to demonstrate the effect of variances in surveillance definitions. Results A total of 357 cases of CDI were reported over the study period – a rate of 3.08 per 10 000 patient care days (95%CI 2.90–3.27) or 0.94 per 1000 patient separations (95%CI 0.91–0.98) for hospital-identified cases of CDI. Yearly rates for the period 2006 to 2010 were 2.3, 3.2, 2.8 and 3.9 per 10 000 patient care days, respectively. The overall trend was an increase in cases over the study period. The CDI rate from 2009–10 was significantly higher than that from 2008–09. Of the total cases reported,64% were healthcare-associated, healthcare-facility onset (HCAHFO), equating to a rate of 2.1 per 10 000 patient care days over the 4-year period. Conclusion The Tasmanian rate of HCA HFO is increasing, and appears to be greater than that reported by other Australian states, but is less than many northern hemisphere regions, where hypervirulent strains of C. difficile are causing increasing morbidity and mortality. It is difficult to compare reported rates of CDI nationally and internationally owing to inconsistencies in study duration, denominator selection, testing effort and testing methodology. This study demonstrates the need for national standards for CDI testing and reporting.